Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction

K. Papalla, D. Bisirtzoglou, V. Anastasakos, A. Zetos, C. Marketos, I. Katsilieris, G. Politis (Athens, Greece)

Source: Annual Congress 2012 - Treatment of lung cancer

Session: Treatment of lung cancer
Session type: Poster Discussion
Number: 2927

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Papalla, D. Bisirtzoglou, V. Anastasakos, A. Zetos, C. Marketos, I. Katsilieris, G. Politis (Athens, Greece). Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction. Eur Respir J 2012; 40: Suppl. 56, 2927

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC) Source: Annual Congress 2009 - Biopsy techniques Year: 2009
Cryotherapy plus chemotherapy or radiation offers increased survival and quality of life in advanced stage lung cancer patients with endobronchial obstruction: Analysis of 160 patients treated with the rigid bronchoscope Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree Year: 2012
High dose rate endobronchial brachytherapy in the palliative management of bronchial cancer - comparison of different doses Source: Eur Respir J 2001; 18: Suppl. 33, 375s Year: 2001
HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Endobronchial brachytherapy in the treatment of malignant lung tumours Source: Eur Respir J 2004; 24: 348-352 Year: 2004
Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology Year: 2012
Electromagnetically navigated bronchoscopy and endobronchial ultrasound for brachytherapy of inoperable peripheral lung cancer – a prospective feasibility and safety study Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009
The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer Source: Eur Respir J 2010; 36: 965-967 Year: 2010
Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease Source: Eur Respir J 2006; 28: Suppl. 50, 610s Year: 2006
Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer? Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Indcution chemotherapy and radiotherapy vs. induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97 Source: Eur Respir J 2006; 28: Suppl. 50, 833s Year: 2006
Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018